Affiliation:
1. Department of Pharmaceutics, Kobe Pharmaceutical University
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference33 articles.
1. 1) Shinjo K, Kondo Y. Targeting cancer epigenetics: linking basic biology to clinical medicine. Adv. Drug Deliv. Rev., 95, 56–64 (2015).
2. 2) Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat. Biotechnol., 28, 1069–1078 (2010).
3. 3) Pluchino KM, Hall MD, Goldsborough AS, Callaghan R, Gottesman MM. Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist. Updat., 15, 98–105 (2012).
4. 4) Tanaka S, Hosokawa M, Yonezawa T, Hayashi W, Ueda K, Iwakawa S. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells. Biol. Pharm. Bull., 38, 435–440 (2015).
5. 5) Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clin. Epigenetics, 7, 127 (2015).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献